| Online-Ressource |
Verfasst von: | Ehrhardt, Manuela [VerfasserIn]  |
| Möck, Marion [VerfasserIn]  |
| Haefeli, Walter E. [VerfasserIn]  |
| Mikus, Gerd [VerfasserIn]  |
| Burhenne, Jürgen [VerfasserIn]  |
Titel: | Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay |
Verf.angabe: | Manuela Ehrhardt, Marion Möck, Walter E. Haefeli, Gerd Mikus, Jürgen Burhenne |
Jahr: | 2007 |
Jahr des Originals: | 2006 |
Umfang: | 10 S. |
Teil: | volume:850 |
| year:2007 |
| number:1 |
| pages:249-258 |
| extent:10 |
Fussnoten: | Online 11 December 2006 ; Gesehen am 12.05.2021 |
Titel Quelle: | Enthalten in: Journal of chromatography / B |
Ort Quelle: | New York, NY [u.a.] : Science Direct, 1977 |
Jahr Quelle: | 2007 |
Band/Heft Quelle: | 850(2007), 1, Seite 249-258 |
ISSN Quelle: | 1873-376X |
Abstract: | For the determination of the HIV protease inhibitors lopinavir and ritonavir in human plasma, plasma ultrafiltrate, and peripheral blood mononuclear cells (PBMCs) a highly sensitive and selective method has been developed, validated, and applied to samples of a healthy volunteer. BD Vacutainer® CPT™ and Amicon Centriplus® centrifugal filter devices were used for separation of PBMCs and for ultrafiltrate generation, respectively. After liquid/liquid-extraction extracts were chromatographed isocratically within 6min on a Jupiter Proteo column. The drugs were quantified using 2H5-saquinavir as internal standard and electrospray tandem mass spectrometry in the selected reaction monitoring mode. Limits of quantification for both analytes were 4.0ng/mL in plasma, 0.2ng/mL in ultrafiltrate, and 0.1ng/cell pellet (∼3×106 cells) in PBMCs. The calibration ranges were linear over more than three logs with an over-all accuracy varying between 98.7% and 111.5% and an over-all precision ranging from 6.2% to 14.0% (SD batch-to-batch). After a regular oral dose of Kaletra® (400mg lopinavir, 100mg ritonavir) analyte concentrations were detectable over a full dosing interval in plasma, ultrafiltrate, and PBMCs. The method is well suited for monitoring of free and total plasma, and intracellular lopinavir/ritonavir concentrations in samples from clinical trials. |
DOI: | doi:10.1016/j.jchromb.2006.11.037 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1016/j.jchromb.2006.11.037 |
| Volltext: https://www.sciencedirect.com/science/article/pii/S1570023206009925 |
| DOI: https://doi.org/10.1016/j.jchromb.2006.11.037 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Kaletra |
| LC/MS/MS |
| Lopinavir |
| PBMC |
| Protein binding |
| Ritonavir |
K10plus-PPN: | 1757720391 |
Verknüpfungen: | → Zeitschrift |
Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay / Ehrhardt, Manuela [VerfasserIn]; 2007 (Online-Ressource)